Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
Cytotherapy
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all
Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all
“Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research.” Cytotherapy.
@article{article43154,
title = {Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all}
}